|Susceptibility to exacerbation in chronic obstructive pulmonary disease|
JR Hurst, J Vestbo, A Anzueto, N Locantore, H Müllerova, R Tal-Singer, ...
New England Journal of Medicine 363 (12), 1128-1138, 2010
|Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease|
GC Donaldson, TAR Seemungal, A Bhowmik, JA Wedzicha
Thorax 57 (10), 847-852, 2002
|Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease|
TAR Seemungal, GC Donaldson, EA Paul, JC Bestall, DJ Jeffries, ...
American journal of respiratory and critical care medicine 157 (5), 1418-1422, 1998
|Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease|
JC Bestall, EA Paul, R Garrod, R Garnham, PW Jones, JA Wedzicha
Thorax 54 (7), 581-586, 1999
|Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary|
CF Vogelmeier, GJ Criner, FJ Martinez, A Anzueto, PJ Barnes, ...
American journal of respiratory and critical care medicine 195 (5), 557-582, 2017
|Chronic obstructive pulmonary disease: molecular and cellularmechanisms|
PJ Barnes, SD Shapiro, RA Pauwels
European Respiratory Journal 22 (4), 672-688, 2003
|Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease|
TAR Seemungal, GC Donaldson, A Bhowmik, DJ Jeffries, JA Wedzicha
American journal of respiratory and critical care medicine 161 (5), 1608-1613, 2000
|Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and …|
JV Lightowler, JA Wedzicha, MW Elliott, FSF Ram
Bmj 326 (7382), 185, 2003
|Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease|
J Bott, MP Carroll, JH Conway, SEJ Keilty, EM Ward, AM Brown, EA Paul, ...
The Lancet 341 (8860), 1555-1557, 1993
|Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease|
T Seemungal, R Harper-Owen, A Bhowmik, I Moric, G Sanderson, ...
American journal of respiratory and critical care medicine 164 (9), 1618-1623, 2001
|The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide|
JA Wedzicha, PMA Calverley, TA Seemungal, G Hagan, Z Ansari, ...
American journal of respiratory and critical care medicine 177 (1), 19-26, 2008
|Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations|
A Bhowmik, TAR Seemungal, RJ Sapsford, JA Wedzicha
Thorax 55 (2), 114-120, 2000
|Outcomes for COPD pharmacological trials: from lung function to biomarkers|
M Cazzola, W MacNee, FJ Martinez, KF Rabe, LG Franciosi, PJ Barnes, ...
European Respiratory Journal 31 (2), 416-469, 2008
|COPD exacerbations: defining their cause and prevention|
JA Wedzicha, TAR Seemungal
The Lancet 370 (9589), 786-796, 2007
|Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations|
IS Patel, TAR Seemungal, M Wilks, SJ Lloyd-Owen, GC Donaldson, ...
Thorax 57 (9), 759-764, 2002
|COPD exacerbations: definitions and classifications|
S Burge, JA Wedzicha
European Respiratory Journal 21 (41 suppl), 46s-53s, 2003
|Non‐invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease|
FSF Ram, J Picot, J Lightowler, JA Wedzicha
Cochrane database of systematic reviews, 2004
|Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease|
TMA Wilkinson, GC Donaldson, JR Hurst, TAR Seemungal, JA Wedzicha
American journal of respiratory and critical care medicine 169 (12), 1298-1303, 2004
|Indacaterol–glycopyrronium versus salmeterol–fluticasone for COPD|
JA Wedzicha, D Banerji, KR Chapman, J Vestbo, N Roche, RT Ayers, ...
New England Journal of Medicine 374 (23), 2222-2234, 2016
|Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD.|
DJ Meecham Jones, EA Paul, PW Jones, JA Wedzicha
American journal of respiratory and critical care medicine 152 (2), 538-544, 1995